title: Diabetes mellitus after renal transplantation under tacrolimus-based immunosuppression.
authors.affiliation: Section of Urology, Yamaguchi Red-Cross Hospital, Yamaguchi, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Suga
authors.forename: Y
authors.initials: Y
authors.lastname: Kishi
authors.forename: Y
authors.initials: Y
authors.lastname: Fujikawa
authors.forename: K
authors.initials: K
authors.lastname: Uchiyama
authors.forename: M
authors.initials: M
authors.lastname: Tsuchida
authors.forename: K
authors.initials: K
authors.lastname: Takai
authors.forename: K
authors.initials: K
authors.lastname: Naito
mesh_terms: D000328:Adult; D003920:Diabetes Mellitus / Q000209:etiology*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000009:adverse effects / Q000276:immunology*; D008210:Lymphocele / Q000209:etiology / Q000601:surgery; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000276:immunology / Q000601:surgery; D016559:Tacrolimus / Q000009:adverse effects*
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus